Rybak M E, Lau H K, Tomkins B, Rosenberg R D, Handin R I
J Clin Invest. 1981 Aug;68(2):405-12. doi: 10.1172/jci110269.
To determine the relationship between platelet secretion and prothrombin conversion in whole blood, the release of platelet factor 4 and the generation of a X(a)-specific cleavage product of prothrombin, fragment 1 + 2, were measured during the coagulation of whole blood. There was a parallel increase in the concentration of the two proteins. Over the first 5 min of incubation, platelet factor 4 concentration increased 6 ng/ml per min, and after 6-7 min, the rate of release increased to 750 ng/ml per min. Over the initial 5-7 min of incubation, fragment 1 + 2 concentration increased 1.5 pmol/ml per min with a subsequent increase of 45 pmol/ml per min. Incubation with 10 muM prostaglandin E(1) or 15 muM prostaglandin I(2) inhibited secretion of platelet factor 4 and delayed the onset of the rapid phase of fragment 1 + 2 generation by 8 min, while stimulation of platelet secretion with 1 mug/ml collagen suspension enhanced production of fragment 1 + 2. The addition of either 10 muM epinephrine or 100 ng/ml collagen suspension to whole blood did not affect either platelet factor 4 release or fragment 1 + 2 generation, although the combination of 3 muM epinephrine and 100 ng/ml collagen suspension enhanced platelet release and prothrombin cleavage. The relationship between platelet factor 4 release and prothrombin cleavage was also studied in Factor VIII-deficient blood. When 0.001 U/ml factor VIII activity was present, <80 ng/ml platelet factor 4 were released, and no fragment 1 + 2 was generated after 30 min of incubation. The addition of 0.008-0.08 U/ml Factor VIII activity progressively increased platelet factor 4 release and prothrombin cleavage. Platelet factor 4 release was normal at 0.08 U/ml Factor VIII activity, whereas prothrombin cleavage was still delayed. Very little thrombin, the amount generated by the cleavage of 3-5 nM fragment 1 + 2, was needed to induce release of platelet factor 4.
为了确定全血中血小板分泌与凝血酶原转化之间的关系,在全血凝固过程中测量了血小板因子4的释放以及凝血酶原的X(a)特异性裂解产物片段1 + 2的生成。两种蛋白质的浓度呈平行增加。在孵育的最初5分钟内,血小板因子4的浓度每分钟增加6 ng/ml,6 - 7分钟后,释放速率增加到每分钟750 ng/ml。在孵育的最初5 - 7分钟内,片段1 + 2的浓度每分钟增加1.5 pmol/ml,随后增加到每分钟45 pmol/ml。用10 μM前列腺素E(1)或15 μM前列腺素I(2)孵育可抑制血小板因子4的分泌,并使片段1 + 2生成的快速期起始延迟8分钟,而用1 μg/ml胶原蛋白悬液刺激血小板分泌可增强片段1 + 2的生成。向全血中添加10 μM肾上腺素或100 ng/ml胶原蛋白悬液对血小板因子4的释放或片段1 + 2的生成均无影响,尽管3 μM肾上腺素与100 ng/ml胶原蛋白悬液的组合可增强血小板释放和凝血酶原裂解。还在缺乏因子VIII的血液中研究了血小板因子4释放与凝血酶原裂解之间的关系。当存在0.001 U/ml的因子VIII活性时,释放的血小板因子4 <80 ng/ml,孵育30分钟后未生成片段1 + 2。添加0.008 - 0.08 U/ml的因子VIII活性可逐渐增加血小板因子4的释放和凝血酶原裂解。在0.08 U/ml的因子VIII活性下,血小板因子4的释放正常,而凝血酶原裂解仍延迟。诱导血小板因子4释放所需的凝血酶量极少,由3 - 5 nM片段1 + 2裂解产生的凝血酶量即可。